Laksh Aithani, CEO of CHARM Therapeutics, discusses key challenges for the flourishing AI drug development sector including finding the right people and the need for more success stories.
First-time CEO Laksh Aithani co-founded CHARM Therapeutics in 2021. The artificial intelligence-driven biotech is discovering and developing small molecule...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
From solving delivery challenges for Moderna's COVID-19 vaccine to pioneering the next generation of programmable medicines, the 2025 Rising Leader provides mid-career reflections.
The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.
A 25-year-old's “naive optimism” becomes the driving force behind one of biopharma's most ambitious AI ventures.
The Stanford professor-turned-CEO's 15-year journey demonstrates how scientific vision and focused leadership can revolutionize pharmaceutical supply chains.
The Japanese pharma specialist has embarked on an ambitious journey to become a global specialty pharmaceutical company, driven by its first non-Japanese president at the helm.
Aviv Regev is betting AI-driven drug discovery can transform Genentech's pipeline, with early wins validating her computational biology approach to pharmaceutical R&D.
The culmination of the MedTech Innovator APAC awards program 2025 comes later this month when the top prizes are handed out at the grand final in Singapore. But all cohort companies benefit from the competition’s mentoring process, says awards organizer Fredrik Nyberg.
